{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:47:44Z","timestamp":1759042064333,"version":"3.33.0"},"reference-count":48,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T00:00:00Z","timestamp":1197936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J of Med Genetics Pt B"],"published-print":{"date-parts":[[2008,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Catechol\u2010<jats:italic>O<\/jats:italic>\u2010methyltransferase (COMT)<jats:italic>Val158Met<\/jats:italic>polymorphism has been identified as a potential etiologic factor in schizophrenia. It has been proposed that this polymorphism could be associated with specific clinical markers. The aim of the study was to evaluate the influence of COMT<jats:italic>Val158Met<\/jats:italic>polymorphism genotype in the phenotypic expression of first episode psychosis at onset. Age of onset, DUP, SANS, and SAPS (positive, disorganized, and negative dimensions) were studied in 169 Caucasian drug\u2010na\u00efve patients with a first\u2010episode of non\u2010affective psychosis. The COMT<jats:italic>Val158Met<\/jats:italic>polymorphism was typed using PCR amplification of the relevant region followed by digestion with<jats:italic>Nla<\/jats:italic>III and electrophoresis. A multivariate ANCOVA was performed with COMT and gender as independent variables. Patients with Val\/Val genotype had significantly higher levels of SANS negative dimension scores (F: 3.539;<jats:italic>P<\/jats:italic>\u2009=\u20090.031) and had a younger age of onset (F: 4.649;<jats:italic>P<\/jats:italic>\u2009=\u20090.011) than Met carriers. Our findings suggest that the Val allele is associated with onset phenotypic features related to a poor prognosis of the illness. These data would indicate that COMT genotype may have a role in the etiological model for schizophrenia and other psychotic disorders. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.b.30639","type":"journal-article","created":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T15:45:20Z","timestamp":1197992720000},"page":"550-556","source":"Crossref","is-referenced-by-count":22,"title":["Catechol\u2010<i>O<\/i>\u2010methyltransferase<i>Val158Met<\/i>polymorphism and clinical characteristics in first episode non\u2010affective psychosis"],"prefix":"10.1002","volume":"147B","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Pelayo\u2010Ter\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedicto","family":"Crespo\u2010Facorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Carrasco\u2010Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"P\u00e9rez\u2010Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jes\u00fas","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Leyva\u2010Cobi\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"V\u00e1zquez\u2010Barquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000292581"},{"volume-title":"Scale for the assessment of negative symptoms (SANS)","year":"1983","author":"Andreasen NC","key":"e_1_2_7_3_1"},{"volume-title":"Scale for the assessment of positive symptoms (SAPS)","year":"1984","author":"Andreasen NC","key":"e_1_2_7_4_1"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)64731-3"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000164591.55942.ea"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01416-6"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/425589"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbj033"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1004"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.111134598"},{"volume-title":"Structured Clinical Interview for DSM\u2010IV Axis I Disorders, Clinician Version (SCID\u2010CV)","year":"1996","author":"First MB","key":"e_1_2_7_12_1"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01973-X"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.469"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00011-5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00125-7"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2004.06.013"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnr.0000192740.38653.91"},{"issue":"1","key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ajmg.b.20023","article-title":"Relationship between catechol\u2010O\u2010methyltransferase polymorphism and treatment\u2010resistant schizophrenia","volume":"120","author":"Inada T","year":"2003","journal-title":"Am J Med Genet Part B"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.4.351"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.7.662"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1614.2004.01338.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199606000-00007"},{"issue":"6","key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1176\/ajp.155.6.835","article-title":"Association between catechol O\u2010methyltransferase genotype and violence in schizophrenia and schizoaffective disorder","volume":"155","author":"Lachman HM","year":"1998","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.1092"},{"volume-title":"Analysis of variance in complex experimental designs","year":"1974","author":"Lindman HR","key":"e_1_2_7_27_1"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054858"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.02139.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ypg.0000218626.26622.a2"},{"issue":"8","key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ajmg.b.30401","article-title":"Catechol\u2010O\u2010methyltransferase and the clinical features of psychosis","volume":"141","author":"McClay JL","year":"2006","journal-title":"Am J Med Genet Part B"},{"key":"e_1_2_7_32_1","article-title":"Clinical involvement of catechol\u2010O\u2010methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment","author":"Molero P","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001664"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200010030-00003"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00100-1"},{"issue":"2","key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/awh702","article-title":"The association between the Val158Met polymorphism of the catechol\u2010O\u2010methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia","volume":"129","author":"Ohnishi T","year":"2006","journal-title":"Brain"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00098-0"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.038"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(96)03111-3"},{"issue":"1","key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.b.20021","article-title":"Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: A replication study","volume":"120","author":"Strous RD","year":"2003","journal-title":"Am J Med Genet Part B"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.09.067"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1159\/000077366"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.10.024"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.2.255"},{"issue":"6","key":"e_1_2_7_45_1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.161.6.1134-a","article-title":"Genetic linkage for schizophrenia?","volume":"161","author":"Volavka J","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"1","key":"e_1_2_7_46_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajmg.b.20149","article-title":"COMT158 polymorphism and hostility","volume":"127","author":"Volavka J","year":"2004","journal-title":"Am J Med Genet Part B"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01252-5"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-2-42"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.56.1.31"}],"container-title":["American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.b.30639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.b.30639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T02:35:16Z","timestamp":1737686116000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.b.30639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,18]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7,5]]}},"alternative-id":["10.1002\/ajmg.b.30639"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.b.30639","archive":["Portico"],"relation":{},"ISSN":["1552-4841","1552-485X"],"issn-type":[{"type":"print","value":"1552-4841"},{"type":"electronic","value":"1552-485X"}],"subject":[],"published":{"date-parts":[[2007,12,18]]}}}